Cargando…
Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade
Therapeutic activation of macrophage phagocytosis has the ability to restrain tumour growth through phagocytic clearance of tumour cells and activation of the adaptive immune response. Our objective for this study was to evaluate the effects of modulating pro- and anti-phagocytic pathways in maligna...
Autores principales: | Anderson, Katie L., Snyder, Kristin M., Ito, Daisuke, Lins, Debra C., Mills, Lauren J., Weiskopf, Kipp, Ring, Nan G., Ring, Aaron M., Shimizu, Yoji, Mescher, Matthew F., Weissman, Irving L., Modiano, Jaime F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6906263/ https://www.ncbi.nlm.nih.gov/pubmed/31205227 http://dx.doi.org/10.1097/CMR.0000000000000629 |
Ejemplares similares
-
CD47-blocking therapies stimulate macrophage cytokine secretion and are effective in a model of peritoneal carcinomatosis
por: Weiskopf, Kipp, et al.
Publicado: (2015) -
CD47 blockade enhances phagocytosis of cardiac cell debris by neutrophils
por: Haj-Yehia, Elias, et al.
Publicado: (2023) -
Macrophages are critical effectors of antibody therapies for cancer
por: Weiskopf, Kipp, et al.
Publicado: (2015) -
CD47 blockade enhances the efficacy of intratumoral STING-targeting therapy by activating phagocytes
por: Kosaka, Akemi, et al.
Publicado: (2021) -
Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPα variants
por: Weiskopf, Kipp, et al.
Publicado: (2013)